ABIOMED Financials

Based on the measurements of operating efficiency obtained from ABIOMED's historical financial statements, ABIOMED is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
With this module, you can analyze ABIOMED financials for your investing period. You should be able to track the changes in ABIOMED individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past ABIOMED Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABIOMED's financial statements are interrelated, with each one affecting the others. For example, an increase in ABIOMED's assets may result in an increase in income on the income statement.
Evaluating ABIOMED's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of ABIOMED's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the ABIOMED's relative financial performance

Chance Of Distress

Over 100

 
100  
 
Zero
Dangerous
ABIOMED has more than 100 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for ABIOMED stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, ABIOMED's odds of distress score SHOULD NOT be confused with the real chance of ABIOMED filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as ABIOMED is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include ABIOMED's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in ABIOMED's official financial statements usually reflect ABIOMED's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABIOMED. For example, before you start analyzing numbers published by ABIOMED accountants, it's critical to develop an understanding of what ABIOMED's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of ABIOMED's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIOMED's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABIOMED's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABIOMED. Please utilize our Beneish M Score to check the likelihood of ABIOMED's management manipulating its earnings.

ABIOMED Company Summary

ABIOMED competes with Ross Stores, Playtika Holding, Mind Technology, Skyworks Solutions, and Renesas Electronics. Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0036541003
Business Address22 Cherry Hill
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.abiomed.com
Phone978 777 8411
CurrencyUSD - US Dollar
You should never invest in ABIOMED without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ABIOMED Stock, because this is throwing your money away. Analyzing the key information contained in ABIOMED's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

ABIOMED Key Financial Ratios

Generally speaking, ABIOMED's financial ratios allow both analysts and investors to convert raw data from ABIOMED's financial statements into concise, actionable information that can be used to evaluate the performance of ABIOMED over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ABIOMED reports annually and quarterly.

ABIOMED Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ABIOMED's current stock value. Our valuation model uses many indicators to compare ABIOMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIOMED competition to find correlations between indicators driving ABIOMED's intrinsic value. More Info.
ABIOMED is number one stock in current asset category among related companies. It is number one stock in shares outstanding category among related companies creating about  0.16  of Shares Outstanding per Current Asset. The ratio of Current Asset to Shares Outstanding for ABIOMED is roughly  6.40 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ABIOMED by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ABIOMED's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABIOMED's earnings, one of the primary drivers of an investment's value.

ABIOMED Market Pulse

 Quote0.0
 Change(%) 0.00  
 Change0.00 
 Open0.0
 Low0.0
 High0.0
 Volume1
 ExchangeNASDAQ

About ABIOMED Financials

What exactly are ABIOMED Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ABIOMED's income statement, its balance sheet, and the statement of cash flows. Potential ABIOMED investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ABIOMED investors may use each financial statement separately, they are all related. The changes in ABIOMED's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ABIOMED's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze ABIOMED Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ABIOMED is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ABIOMED has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if ABIOMED's financials are consistent with your investment objective using the following steps:
  • Review ABIOMED's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand ABIOMED's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare ABIOMED's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if ABIOMED's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

ABIOMED Thematic Clasifications

ABIOMED is part of several thematic ideas from Obamacare to Obamacare Repeal. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

ABIOMED March 19, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ABIOMED help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABIOMED. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABIOMED based on widely used predictive technical indicators. In general, we focus on analyzing ABIOMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABIOMED's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in ABIOMED Stock

If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements